01076nas a2200385   4500000000100000000000100001000000100002008004100003653001100044653005100055653001100106653000900117653001000126653001500136653005300151653001600204653001600220653002700236653002600263653005000289653004800339100001400387700001400401700001500415700001500430700001700445700001400462700001100476700001400487245014000501250001500641300001300656490000700669020001400676       2024                            d10aHumans10a*Valproic Acid/adverse effects/therapeutic use10aFemale10aMale10aAdult10aAdolescent10a*Anticonvulsants/adverse effects/therapeutic use10aMiddle Aged10aYoung Adult10a*Epilepsy/drug therapy10aRetrospective Studies10aLevetiracetam/therapeutic use/adverse effects10aLamotrigine/adverse effects/therapeutic use1 aG. Mbizvo1 aG. Martin1 aM. Sperrin1 aL. Bonnett1 aP. Schofield1 aI. Buchan1 aG. Lip1 aA. Marson00aAn international study to investigate and optimise the safety of discontinuing valproate in young men and women with epilepsy: Protocol  a2024/08/31  ae03062260 v19  a1932-6203